ALLOGENEIC CELL THERAPY FOR B LYMPHOCYTE MALIGNITIES USING GENETICALLY MODIFIED T LYMPHOCYTES TARGETING CD19
MA55797AUndetermined Publication Date: 2022-03-09CRISPR THERAPEUTICS AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA55797
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-04-30
- Filing Date
- 2020-04-30
- Publication Date
- 2022-03-09
Need to check novelty before this filing date? Find Prior Art
No text content released.